$4.59
-0.14-2.96%
Last update: 3:10 PM
15 minutes delayed
Comments
Loading...
Kyverna Therapeutics (KYTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKyverna Therapeutics (NASDAQ:KYTX) Stock Quotes, Forecast and News Summary
Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kyverna Therapeutics (KYTX) stock?
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Who are Kyverna Therapeutics (KYTX) competitors?
Other companies in Kyverna Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA) and Galectin Therapeutics (NASDAQ:GALT).
What is the forecast, or price target, for Kyverna Therapeutics (KYTX) stock?
Kyverna Therapeutics has a consensus price target of $26.67.
What is the current price for Kyverna Therapeutics (KYTX)?
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $4.73 last updated October 2, 2024 at 4:00 PM EDT.
Does Kyverna Therapeutics (KYTX) pay a dividend?
There are no upcoming dividends for Kyverna Therapeutics.
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Kyverna Therapeutics (KYTX) going to split?
There is no upcoming split for Kyverna Therapeutics.
What sector and industry does Kyverna Therapeutics (KYTX) operate in?
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.